Ehrlich Christopher B 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Feb 26, 2025
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-02-24+1,275,000→ 2,550,000 totalExercise: $0.10Exp: 2034-09-30→ Common Stock (1,275,000 underlying)
Footnotes (1)
- [F1]On October 1, 2024, the Reporting Person was granted an option to purchase 2,550,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On February 24, 2025, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to the second installment, resulting in the vesting of 1,275,000 shares.